Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
ViroMissile, Inc.
Cancer Research UK
University of Florida
University of Nebraska
Fusion Pharmaceuticals Inc.